Stock analysts at StockNews.com assumed coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a research report issued to clients and investors on Tuesday. The firm set a “hold” rating on the stock. Can-Fite BioPharma Stock Performance Shares of NYSE CANF opened at $2.09 on Tuesday. The company has a market capitalization […]
Investment analysts at StockNews.com initiated coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a note issued to investors on Tuesday. The firm set a “hold” rating on the stock. Can-Fite BioPharma Price Performance Can-Fite BioPharma stock opened at $2.09 on Tuesday. Can-Fite BioPharma has a one year low of $1.76 and […]
StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a report published on Thursday morning. The firm issued a hold rating on the stock. Can-Fite BioPharma Stock Up 1.8 % Shares of CANF opened at $2.23 on Thursday. Can-Fite BioPharma has a 52 week low of $1.52 and a 52 week […]
StockNews.com assumed coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a report issued on Sunday. The brokerage issued a hold rating on the stock. Separately, HC Wainwright cut their target price on Can-Fite BioPharma from $34.00 to $18.00 and set a buy rating on the stock in a research report on Tuesday, […]
Equities researchers at StockNews.com assumed coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a report issued on Thursday. The firm set a “hold” rating on the stock. Separately, HC Wainwright decreased their price target on Can-Fite BioPharma from $34.00 to $18.00 and set a “buy” rating on the stock in a […]